Medistim ASA (STO:MEDIO)

Market Cap	3.91B
Revenue (ttm)	576.25M
Net Income (ttm)	117.25M
Shares Out	n/a
EPS (ttm)	6.40
PE Ratio	33.37
Forward PE	31.68
Dividend	n/a
Ex-Dividend Date	n/a

Volume	350
Average Volume	531
Open	233.00
Previous Close	210.00
Day's Range	233.00 - 240.00
52-Week Range	131.00 - 240.00
Beta	n/a
RSI	62.73
Earnings Date	Aug 20, 2025

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1984
• Employees: 154
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MEDIO

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.

Financial numbers in NOK